These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 16153197

  • 1. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Boorjian SA, Bianco FJ, Scardino PT, Eastham JA.
    BJU Int; 2005 Oct; 96(6):773-6. PubMed ID: 16153197
    [Abstract] [Full Text] [Related]

  • 2. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A, Murai M, Baba S, Ogawa O, Tsukamoto T, Niwakawa M, Tobisu K, Kinukawa N, Naito S.
    BJU Int; 2006 Sep; 98(3):549-53. PubMed ID: 16925752
    [Abstract] [Full Text] [Related]

  • 3. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC.
    Cancer; 2003 Dec 01; 98(11):2344-50. PubMed ID: 14635068
    [Abstract] [Full Text] [Related]

  • 4. The relationship between age at time of surgery and risk of biochemical failure after radical prostatectomy.
    Barlow LJ, Badalato GM, Bashir T, Benson MC, McKiernan JM.
    BJU Int; 2010 Jun 01; 105(12):1646-9. PubMed ID: 19863523
    [Abstract] [Full Text] [Related]

  • 5. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
    BJU Int; 2006 Jan 01; 97(1):51-5. PubMed ID: 16336328
    [Abstract] [Full Text] [Related]

  • 6. Site of positive surgical margins influences biochemical recurrence after radical prostatectomy.
    Godoy G, Tareen BU, Lepor H.
    BJU Int; 2009 Dec 01; 104(11):1610-4. PubMed ID: 19549257
    [Abstract] [Full Text] [Related]

  • 7. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM, Babaian K, Cheung MR, Naya Y, Huang SH, Kuban D, Babaian RJ.
    J Urol; 2003 Nov 01; 170(5):1860-3. PubMed ID: 14532793
    [Abstract] [Full Text] [Related]

  • 8. Reasonable delay of surgical treatment in men with localized prostate cancer--impact on prognosis?
    Graefen M, Walz J, Chun KH, Schlomm T, Haese A, Huland H.
    Eur Urol; 2005 Jun 01; 47(6):756-60. PubMed ID: 15925069
    [Abstract] [Full Text] [Related]

  • 9. A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
    Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, Gibbons RP, Correa R, Montorsi F, Graefen M, Huland H, Klein EA, Karakiewicz PI.
    Cancer; 2008 Mar 15; 112(6):1254-63. PubMed ID: 18286530
    [Abstract] [Full Text] [Related]

  • 10. Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen.
    San Francisco IF, Regan MM, Olumi AF, DeWolf WC.
    J Urol; 2004 Apr 15; 171(4):1492-9. PubMed ID: 15017206
    [Abstract] [Full Text] [Related]

  • 11. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
    Bianco FJ, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):448-53. PubMed ID: 15890586
    [Abstract] [Full Text] [Related]

  • 12. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.
    Moul JW, Wu H, Sun L, McLeod DG, Amling C, Donahue T, Kusuda L, Sexton W, O'Reilly K, Hernandez J, Chung A, Soderdahl D.
    J Urol; 2004 Mar 01; 171(3):1141-7. PubMed ID: 14767288
    [Abstract] [Full Text] [Related]

  • 13. Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer.
    D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP.
    Mol Urol; 2000 Mar 01; 4(3):171-5;discussion 177. PubMed ID: 11062371
    [Abstract] [Full Text] [Related]

  • 14. Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference?
    Pelzer AE, Colleselli D, Bektic J, Steiner E, Ramoner R, Mitterberger M, Schwentner C, Schaefer G, Ongarello S, Bartsch G, Horninger W.
    BJU Int; 2008 Apr 01; 101(7):822-5. PubMed ID: 18261154
    [Abstract] [Full Text] [Related]

  • 15. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O, Eggener SE, Bianco FJ, Carver BS, Serio A, Scardino PT, Eastham JA.
    J Urol; 2007 Aug 01; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [Abstract] [Full Text] [Related]

  • 16. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA, Shappell SB, Chang SS, Wells N, Farnham SB, Smith JA, Cookson MS.
    BJU Int; 2006 Jun 01; 97(6):1169-72. PubMed ID: 16686706
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA.
    Eur Urol; 2009 Feb 01; 55(2):404-10. PubMed ID: 18639970
    [Abstract] [Full Text] [Related]

  • 19. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H.
    BJU Int; 2005 Apr 01; 95(6):751-6. PubMed ID: 15794776
    [Abstract] [Full Text] [Related]

  • 20. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.
    D'Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, Chen MH, Tomaszewski JE, Renshaw AA, Wein A, Richie JP.
    Cancer; 2002 Jul 15; 95(2):281-6. PubMed ID: 12124827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.